Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 58 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
571 16.6 months Hepatocellular carcinoma 4 Chemotherapy
National Cancer Center Hospital East Japan 12/2010
Treatment Details: Patients: This phase II study involved 23 patients with advanced hepatocellular carcinoma (HCC) who had a median age of 68 years and 91.3% were male. Treatment: Patients were treated wi
 
572 16.6 months GBM 5 Biologic therapy
Chemotherapy
Radiation
Dana Farber Cancer Institute United States 4/2015
Treatment Details: Patients: This phase 2 study involved newly diagnosed glioblastoma patients who were divided into two separate treatment groups. Group A consisted of 36 patients with a median age of 55 yea
 
573 16.6 months Ovarian Cancer 5 Biologic therapy
Chemotherapy
Université Paris Descartes France 5/2014
Treatment Details: Patients: This phase 3 study involved ovarian cancer patients who had received prior platinum-based chemotherapy and were divided into two separate treatment groups. Group A consisted of 18
 
574 16.6 months Anaplastic glioma 5 Biologic therapy
Chemotherapy
The University of Texas MD Anderson Cancer Center United States 11/2011
Treatment Details: Patients: This phase II trial involved 39 patients with anaplastic glioma. The median patient age was 43 years and 62% were male. Treatment: Patients were treated with the chemotherapy
 
575 16.6 months Platinum resistant ovarian cancer 4 Biologic therapy
Chemotherapy
Women's Cancer Care of Seattle United States 8/2011
Treatment Details: Patients: This study involved 40 women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer with a median patient age of 58.6 years. All patients had received prior platin
 
576 16.6 months Newly diagnosed GBM 5 Chemotherapy
Radiation
MD Anderson Cancer Center United States 11/2013
Treatment Details: Patients: This phase 3 study involved newly diagnosed glioblastoma patients who were divided into two separate treatment groups. Group A had 411 patients of whom 27% were younger than 50 y
 
577 16.5 months Recurrent platinum-resistant ovarian cancer 4 Chemotherapy
Regina Elena National Cancer Institute Italy 8/2013
Treatment Details: Patients: This phase 2 study involved 41 recurrent, platinum-resistant ovarian cancer patients who had previously received platinum-based chemotherapy. The median patient age was 60 years.
 
578 16.5 months advanced and metastatic breast cancer 4 Chemotherapy
Vall d'Hebron University Hospital Spain 8/2005
Treatment Details: Patients: This Phase II study involved 31 women with advanced or metastatic breast cancer. The median age was 57 years. Metastatic sites included skin, bone, soft tissue, and lymph nodes.
 
579 16.5 months Advanced colorectal cancer 4 Chemotherapy
Vienna University Medical School Austria 1/2002
Treatment Details: Patients: This Phase II study involved 92 patients with previously untreated advanced colorectal cancer. Forty-six patients were randomized to group A (arm A) and forty-six patients were r
 
580 16.5 months Newly diagnosed advanced colorectal cancer 4 Chemotherapy
Vienna University Medical School Austria 1/2002
Treatment Details: Patients: This Phase II study involved 92 patients with previously untreated advanced colorectal cancer. Forty-six patients were randomized to group A (arm A) and forty-six patients were r
 
Page 58 of 187  | Previous Page  | Next Page